Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome.

CONCLUSIONS: This case review illustrates the wide heterogeneity in antithrombotic pharmacotherapy among AF patients presenting with STEMI > 12 months after PCI. The underlying reason for STEMI is only partly related to disease progression or stent-related events. This finding suggests that multiple mechanisms of recurrence may be advocated, and are not only limited to antithrombotic therapy but may be explained by the natural history of coronary artery disease in remote vessels.
PMID: 31960945 [PubMed - as supplied by publisher]

Source: Cardiology Journal - January 20, 2020 Category: Cardiology Authors: Franchina AG, Calderone D, D'Arrigo P, Ingala S, Milluzzo RP, Greco A, Spagnolo M, Tamburino C, Capodanno D Tags: Cardiol J Source Type: research